ZYDUSLIFE

Zydus Lifesciences Cash Flow

₹1,151.30-0.71%
Market cap
₹1.16 lakh crore
P/E
25.7
P/B
4.27
ROE
19.7%
Dividend yield
0.09%

In the year ended Mar 2022, Zydus Lifesciences generated ₹1,400 crore from operating activities, invested ₹600 crore and paid out ₹550 crore on financing activities. Net cash flow for the year was ₹250 crore. Free cash flow was ₹950 crore.

Zydus Lifesciences cash flow statement

Financial years, newest first. Negative figures are cash outflows.

Zydus Lifesciences cash flows (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activities1,4002,6893,1966,7812,117
Cash from investing activities-6001,535-1,475-8,358-8,296
Cash from financing activities-550-4,400-1,7791,9955,807
Net cash flow250-170-81397-162
Capital expenditure—————
Free cash flow9501,6582,2905,087-555

Source: Company filings, in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Zydus Lifesciences cash flow — frequently asked questions

What is Zydus Lifesciences' operating cash flow?

Zydus Lifesciences' cash flow from operating activities was ₹1,400 crore in the year ended Mar 2022, fell 47.94% from ₹2,689 crore in Mar 2023.

What is Zydus Lifesciences' free cash flow?

Zydus Lifesciences' free cash flow — operating cash flow minus capital expenditure — was ₹950 crore in Mar 2022.

How much did Zydus Lifesciences spend on investing activities?

Net cash used in investing activities was ₹600 crore in Mar 2022. This covers capital expenditure, acquisitions and the purchase or sale of investments.

Same Data For Peers

Trade Zydus Lifesciences With ATS

Track ZYDUSLIFE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.